Goretzki Benedikt, Khoshouei Maryam, Schröder Martin, Penner Patrick, Egger Luca, Stephan Christine, Argoti Dayana, Dierlamm Nele, Rada Jimena Maria, Kapps Sandra, Müller Catrin Swantje, Thiel Zacharias, Mutlu Merve, Tschopp Claude, Furkert David, Freuler Felix, Haenni Simon, Tenaillon Laurent, Knapp Britta, Hinniger Alexandra, Hoppe Philipp, Schmidt Enrico, Gutmann Sascha, Iurlaro Mario, Ryzhakov Grigory, Fernández César
Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.
Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.
Cell. 2024 Dec 26;187(26):7585-7602.e25. doi: 10.1016/j.cell.2024.11.006. Epub 2024 Dec 9.
Broad-complex, tramtrack, and bric-à-brac domain (BTB) and CNC homolog 1 (BACH1) is a key regulator of the cellular oxidative stress response and an oncogene that undergoes tight post-translational control by two distinct F-box ubiquitin ligases, SCF and SCF. However, how both ligases recognize BACH1 under oxidative stress is unclear. In our study, we elucidate the mechanism by which FBXO22 recognizes a quaternary degron in a domain-swapped β-sheet of the BACH1 BTB dimer. Cancer-associated mutations and cysteine modifications destabilize the degron and impair FBXO22 binding but simultaneously expose an otherwise shielded degron in the dimer interface, allowing FBXL17 to recognize BACH1 as a monomer. These findings shed light on a ligase switch mechanism that enables post-translational regulation of BACH1 by complementary ligases depending on the stability of its BTB domain. Our results provide mechanistic insights into the oxidative stress response and may spur therapeutic approaches for targeting oxidative stress-related disorders and cancer.
广泛复合体、轨道样蛋白和杂乱结构域(BTB)与CNC同源物1(BACH1)是细胞氧化应激反应的关键调节因子,也是一种癌基因,它受到两种不同的F-box泛素连接酶SCF和SCF的严格翻译后调控。然而,在氧化应激条件下这两种连接酶如何识别BACH1尚不清楚。在我们的研究中,我们阐明了FBXO22识别BACH1 BTB二聚体结构域交换β-折叠中的四级降解子的机制。癌症相关突变和半胱氨酸修饰会使降解子不稳定并损害FBXO22的结合,但同时会暴露二聚体界面中原本被屏蔽的降解子,从而使FBXL17能够将BACH1识别为单体。这些发现揭示了一种连接酶切换机制,该机制能够根据BACH1 BTB结构域的稳定性,通过互补连接酶对其进行翻译后调控。我们的结果为氧化应激反应提供了机制性见解,并可能推动针对氧化应激相关疾病和癌症的治疗方法。